Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Current Status and Prognosis of Coronary artery disease patients treated with coronary intervention - Analysis of the Korean Nationwide Health Insurance Database
This is a retrospective study and is conducted for all patients who received percutaneous coronary intervention among cohorts registered with the National Health Insurance Service.
Primary outcome is all cause of mortality. Secondary outcomes are cardiovascular death, ischemic stroke, cerebral hemorrhage, admission due to gastrointestinal bleeding, and admission due to major bleedings.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| drug-eluting stent | Device | A group of percutaneous coronary intervention (PCI) using drug-eluting stents (DES) |
| |
| drug-coated balloon | Device | A group of percutaneous coronary intervention (PCI) using drug-coated balloon (DCB) |
|
| Measure | Description | Time Frame |
|---|---|---|
| All cause of death | 'All cause of death' will be recorded as number of participants with 'All cause of death' | 10 years |
| Measure | Description | Time Frame |
|---|---|---|
| Cardiovascular death | 'Cardiovascular death' will be recorded as number of participants with 'Cardiovascular death' | 10 years |
| ischemic stroke | 'ischemic stroke' will be recorded as number of participants with 'ischemic stroke' |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
All coronary artery disease patients wih Korean NHIS (National Health Insurance Service)-listed PCI Patients are selected based on the registered treatment insurance code.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Han-Mo Yang, MD, PhD | Contact | 8220722677 | hanname@gmail.com | |
| Hak Seung Lee, MD | Contact | 821031668399 | cardiolee@gmail.com |
Not provided
Not provided
Since this research is conducted with a national public institution, data cannot be shared.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003324 | Coronary Artery Disease |
| ID | Term |
|---|---|
| D003327 | Coronary Disease |
| D017202 | Myocardial Ischemia |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D054855 | Drug-Eluting Stents |
| ID | Term |
|---|---|
| D015607 | Stents |
| D019736 | Prostheses and Implants |
| D004864 | Equipment and Supplies |
Not provided
Not provided
Not provided
Not provided
Not provided
| 10 years |
| Cerebral hemorrhage | 'Cerebral hemorrhage' will be recorded as number of participants with 'Cerebral hemorrhage' | 10 years |
| Admission due to gastrointestinal bleeding | 'Admission due to gastrointestinal bleeding' will be recorded as number of participants with 'Admission due to gastrointestinal bleeding' | 10 years |
| Admission due to major bleeding | 'Admission due to major bleeding' will be recorded as number of participants with 'Admission due to major bleeding' Thismeasure is a composite outcome, which includes cerebral hemorrhage, admission due to gastrointestinal bleeding. | 10 years |
| D001161 |
| Arteriosclerosis |
| D001157 | Arterial Occlusive Diseases |
| D014652 | Vascular Diseases |